title: The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program.
abstract: OBJECTIVE
  To compare two gonadotropin-releasing hormone agonists (GnRH-a), buserelin acetate and leuprolide acetate [LA], used in combination with gonadotropins in ovarian stimulation for in vitro fertilization (IVF).
  
  
  METHODS
  Randomized prospective study.
  
  
  METHODS
  Assisted Reproduction Unit of the Hospital Clínic i Provincial in Barcelona.
  
  
  METHODS
  Thirty-five pairs of IVF patients who were matched on age, indication, and number of attempts. These women were randomized to receive either buserelin acetate plus gonadotropins (group B) or LA plus gonadotropins (group L).
  
  
  METHODS
  Luteolysis, ovarian response, and IVF outcome.
  
  
  RESULTS
  The mean time for total ovarian arrest and the total dose of gonadotropins and estradiol levels on the day of human chorionic gonadotropin administration were similar in the two groups of patients. The number of follicles punctured, the number of oocytes retrieved, and the percentage of mature oocytes in group L were significantly higher. The number of embryos suitable for replacement and cryopreservation was higher in group L compared with group B approaching statistical significance.
  
  
  CONCLUSIONS
  Our results warrant further studies to compare different GnRH-a as therapeutic tools in IVF.
authors.affiliation: Department of Obstetrics and Gynecology, Faculty of Medicine, Hospital Clínic i Provincial, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Balasch
authors.forename: I C
authors.initials: IC
authors.lastname: Jové
authors.forename: V
authors.initials: V
authors.lastname: Moreno
authors.forename: S
authors.initials: S
authors.lastname: Civico
authors.forename: B
authors.initials: B
authors.lastname: Puerto
authors.forename: J A
authors.initials: JA
authors.lastname: Vanrell
mesh_terms: D000328:Adult; D002064:Buserelin / Q000008:administration & dosage / Q000627:therapeutic use*; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000627:therapeutic use; D003338:Corpus Luteum / Q000502:physiology; D015925:Cryopreservation; D004622:Embryo, Mammalian / Q000502:physiology; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D007246:Infertility / Q000628:therapy; D016729:Leuprolide / Q000008:administration & dosage / Q000627:therapeutic use*; D009865:Oocytes / Q000502:physiology; D011247:Pregnancy; D011446:Prospective Studies; D011897:Random Allocation
chemical_list: D006063:Chorionic Gonadotropin; D004958:Estradiol; D016729:Leuprolide; D002064:Buserelin